Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-01

Clinical Trial Update: A Clinical Study of Tranilast in the Treatment of Scleredema Diabeticorum [EARLY_Phase 1]

View source ↗

Summary

A clinical trial update describing a phase 1 study of tranilast for scleredema (adultorum) and scleredema diabeticorum.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tranilast (tranilast)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Scleredema Adultorum | EARLY_Phase 1 | Status: UNKNOWN